Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis

Clinica Chimica Acta

Volumn 505, Issue , 2020, Pages 190-191

  Lippi, Giuseppe ^a   Plebani, Mario ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Coronavirus; COVID 19; Procalcitonin; Prognosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROCALCITONIN; TUMOR NECROSIS FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CLINICAL DECISION MAKING; CORONAVIRINAE; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; DISEASE SEVERITY; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LETTER; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; BETACORONAVIRUS; BLOOD; LABORATORY TECHNIQUE; META ANALYSIS; PANDEMIC; RISK FACTOR; VIRUS PNEUMONIA;

BETACORONAVIRUS; CLINICAL LABORATORY TECHNIQUES; CORONAVIRUS INFECTIONS; HUMANS; PANDEMICS; PNEUMONIA, VIRAL; PROCALCITONIN; RISK FACTORS;

EID: 85081226278     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2020.03.004     Document Type: Letter

References (11)

1. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 49. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Last accessed, March 9, 2020.
2. Mattiuzzi, C., Lippi, G., Which lessons shall we learn from the 2019 novel coronavirus outbreak?. Ann. Transl. Med., 8, 2020, 48.
3. Cervellin, G., Schuetz, P., Lippi, G., Toward a holistic approach for diagnosing sepsis in the emergency department. Adv. Clin. Chem. 92 (2019), 201–216.
4. Schuetz, P., Albrich, W., Mueller, B., Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med., 9, 2011, 107.
5. Guan, Wei-jie, Ni, Zheng-yi, Hu, Yu, Liang, Wen-hua, Ou, Chun-quan, He, Jian-xing, Liu, Lei, Shan, Hong, Lei, Chun-liang, Hui, David S.C., Du, Bin, Li, Lan-juan, Zeng, Guang, Yuen, Kwok-Yung, Chen, Ru-chong, Tang, Chun-li, Wang, Tao, Chen, Ping-yan, Xiang, Jie, Li, Shi-yue, Wang, Jin-lin, Liang, Zi-jing, Peng, Yi-xiang, Wei, Li, Liu, Yong, Hu, Ya-hua, Peng, Peng, Wang, Jian-ming, Liu, Ji-yang, Chen, Zhong, Li, Gang, Zheng, Zhi-jian, Qiu, Shao-qin, Luo, Jie, Ye, Chang-jiang, Zhu, Shao-yong, Zhong, Nan-shan, Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med., 2020, 10.1056/NEJMoa2002032.
6. Zhang, J.J., Dong, X., Cao, Y.Y., Yuan, Y.D., Yang, Y.B., Yan, Y.Q., et al. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy, 2020, 10.1111/all.14238 (Epub ahead of print).
7. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020), 497–506.
8. Wang, Dawei, Hu, Bo, Hu, Chang, Zhu, Fangfang, Liu, Xing, Zhang, Jing, Wang, Binbin, Xiang, Hui, Cheng, Zhenshun, Xiong, Yong, Zhao, Yan, Li, Yirong, Wang, Xinghuan, Peng, Zhiyong, Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA, 2020, 10.1001/jama.2020.1585.
9. Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
10. Lippi, Giuseppe, Plebani, Mario, Laboratory abnormalities in patients with COVID-2019 infection. Clin. Chem. Lab. Med., 2020, 10.1515/cclm-2020-0198.
11. Kotula, J.J. 3rd, Moore, W.S. 2nd, Chopra, A., Cies, J.J., Association of procalcitonin value and bacterial coinfections in pediatric patients with viral lower respiratory tract infections admitted to the pediatric intensive care unit. J. Pediatr. Pharmacol. Ther. 23 (2018), 466–472.